| Advances in cord blood transplants in adults. | |
| | |
MedLine Citation:
|
PMID: 20948874 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Umbilical cord blood is an acceptable source of hematopoietic stem cells for patients with malignant diseases but has limitations in its use. In this review, we will discuss these limitations and the recent advances in cord blood transplants that may enable cord blood to become more widely available as an alternative stem cell source for adults for the treatment of malignant diseases and for use in regenerative medicine. |
| | |
Authors:
|
Phuong L Doan; Nelson J Chao |
Related Documents
:
|
2109294 - Umbilical cord blood gas assessment of twins. 3898694 - Serum thymidine activity and insulin-like growth factors in the neonatal period. 7815584 - Papaverine topical gel for treatment of erectile dysfunction. 6934544 - Cord-blood tyrosine levels in the full-term phenylketonuric fetus and the "justificatio... 12063304 - Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid pr... 1192704 - The role of baroreceptors and chemoreceptors in the regulation of the cerebral circulat... |
Publication Detail:
|
Type: Journal Article Date: 2010-02-11 |
Journal Detail:
|
Title: F1000 medicine reports Volume: 2 ISSN: 1757-5931 ISO Abbreviation: F1000 Med Rep Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-10-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101506841 Medline TA: F1000 Med Rep Country: England |
Other Details:
|
Languages: eng Pagination: - Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Update on bioagent therapy in sarcoidosis.
Next Document: Recent advances in managing hepatitis B.